N-[(heteroaryloxy)propanyl]heteroaryl carboxamides as antagonists of orexin subtype 1 receptor activity
申请人:Boehringer Ingelheim International GmbH
公开号:US10738031B2
公开(公告)日:2020-08-11
This invention relates to compounds of formula (I), a process for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions having an association with the orexin sub-type 1 receptor. Ar1 and Ar2 have meanings given in the description.
本发明涉及式(I)化合物、其制备方法、含有它们的药物组合物以及它们在治疗与奥曲肽亚型 1 受体有关的疾病中的用途。Ar1 和 Ar2 的含义在描述中给出。